As of close of business last night, Illumina Inc’s stock clocked out at $130.70, down -0.36% from its previous closing price of $131.17. In other words, the price has decreased by -$0.47 from its previous closing price. On the day, 1082597 shares were traded. ILMN stock price reached its highest trading level at $133.21 during the session, while it also had its lowest trading level at $128.08.
Ratios:
To gain a deeper understanding of ILMN’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 19.70 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 73.65. For the most recent quarter (mrq), Quick Ratio is recorded 1.29 and its Current Ratio is at 1.66. In the meantime, Its Debt-to-Equity ratio is 0.39 whereas as Long-Term Debt/Eq ratio is at 0.38.
On January 04, 2024, TD Cowen Downgraded its rating to Market Perform which previously was Outperform but kept the price unchanged to $144.
Scotiabank Upgraded its Sector Perform to Sector Outperform on December 18, 2023, while the target price for the stock was maintained at $185.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Feb 22 ’24 when Thaysen Jacob bought 7,330 shares for $135.29 per share. The transaction valued at 991,672 led to the insider holds 14,861 shares of the business.
Hoyt Aimee L sold 315 shares of ILMN for $35,545 on Nov 07 ’23. The SVP, Chief People Officer now owns 8,314 shares after completing the transaction at $112.84 per share. On Aug 22 ’23, another insider, TOUSI SUSAN H, who serves as the SVP, Chief Commercial Officer of the company, sold 500 shares for $167.04 each. As a result, the insider received 83,520 and left with 45,524 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ILMN now has a Market Capitalization of 20.80B and an Enterprise Value of 22.01B. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.61 while its Price-to-Book (P/B) ratio in mrq is 3.62. Its current Enterprise Value per Revenue stands at 4.89 whereas that against EBITDA is -36.20.
Stock Price History:
Over the past 52 weeks, ILMN has reached a high of $232.88, while it has fallen to a 52-week low of $89.00. The 50-Day Moving Average of the stock is 136.28, while the 200-Day Moving Average is calculated to be 142.17.
Shares Statistics:
It appears that ILMN traded 1.73M shares on average per day over the past three months and 1.56M shares per day over the past ten days. A total of 159.00M shares are outstanding, with a floating share count of 158.11M. Insiders hold about 0.50% of the company’s shares, while institutions hold 90.81% stake in the company. Shares short for ILMN as of Mar 28, 2024 were 5.28M with a Short Ratio of 3.06, compared to 4.95M on Feb 29, 2024. Therefore, it implies a Short% of Shares Outstanding of 3.32% and a Short% of Float of 3.75%.
Earnings Estimates
As of right now, 15 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of $0.04 for the current quarter, with a high estimate of $0.25 and a low estimate of -$0.11, while EPS last year was $0.08. The consensus estimate for the next quarter is $0.15, with high estimates of $0.25 and low estimates of $0.
Analysts are recommending an EPS of between $1.38 and $0.43 for the fiscal current year, implying an average EPS of $0.89. EPS for the following year is $2.44, with 19 analysts recommending between $4.53 and $1.05.
Revenue Estimates
In the current quarter, 14 analysts expect revenue to total $1.05B. It ranges from a high estimate of $1.06B to a low estimate of $1.03B. As of the current estimate, Illumina Inc’s year-ago sales were $1.09B, an estimated decrease of -3.20% from the year-ago figure. For the next quarter, 13 analysts are estimating revenue of $1.11B, a decrease of -4.70% less than the figure of -$3.20% in the same quarter last year. There is a high estimate of $1.15B for the next quarter, whereas the lowest estimate is $1.06B.
Based on 19 analysts’ estimates, the company’s revenue will be $4.86B in the next fiscal year. The high estimate is $5.13B and the low estimate is $4.42B. The average revenue growth estimate for next year is up 7.90% from the average revenue estimate for this year.
